Igentify

📍 Haifa, Israel🗓 Founded 2016👥 56 employees💰 Last funded Feb 2019
Igentify® is a digital health company. We help clinicians, laboratories, and patients access, interpret, and use genetic information and education more effectively. Igentify developed the world’s first Digital Genetic Assistant, a software-based decision support platform. Our platform is capable of providing a fully scalable end-to-end genetic counseling solution in both clinical as well as non-clinical (direct-to-consumer) genetic testing set up. The platform is built for various genotyping technologies like microarray and next-generation sequencing (NGS). It can be customized to a broad spectrum of genetic and genomic tests offered by the test providers. Founded in Oct. 2016, Igentify’s team of globally renowned geneticists, highly experienced software developers, creative animators, and UX/UI designers, is redefining the protocols of traditional medicine. In Jan. 2019, Deloitte selected Igentify as one of the Israeli startups at the forefront of the Digital R&D Revolution.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Igentify?
Igentify has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Igentify last raise funding?
The most recent investment in Igentify recorded on gritt.io was in February 2019.
When was Igentify founded?
Igentify was founded in 2016.
What industry is Igentify in?
Igentify operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Igentify based?
Igentify is headquartered in Haifa, Israel.